Farid Arman, MD
- Nephrology
About
Dr. Farid Arman is a board-certified nephrologist at UCLA Health, dedicated to delivering expert, compassionate kidney care across multiple locations, including the Connie Frank Kidney Transplant Center, UCLA Downtown Los Angeles, and the Santa Monica Nephrology and Infectious Diseases clinic. He is committed to improving patient outcomes through a comprehensive, patient-centered approach.
Dr. Arman earned his medical degree from Shahid Beheshti University of Medical Sciences in Tehran, Iran, in 2013. He completed his internal medicine internship at the University of Pittsburgh Medical Center, followed by a residency in internal medicine at Mount Sinai Hospital in 2022. He then completed a fellowship in nephrology at Columbia Presbyterian Irving Medical Center, where he trained in advanced management of kidney disorders.
His clinical interests include glomerulonephritis (including IgA nephropathy and membranous nephropathy, among others), genetic kidney diseases, and hepatorenal syndrome. In addition to his clinical work, Dr. Arman is actively involved in academic medicine and values the integration of evidence-based care and medical education.
Languages
Education
Medical Board Certifications
Fellowship
Residency
Internship
Degree
Related Clinical Trials
Locations
Connie Frank Kidney Transplant Center
Santa Monica Nephrology and Infectious Diseases
Downtown LA Primary & Specialty Care
Hospital Affiliations
Research
Interests
Genetic kidney diseases, IgA nephropathy, membranous nephroapthy, ANCA vasculitis, and hepatorenal syndrome.
Publications
- Navigating Novel Therapeutics for IgA Nephropathy: Literature Review
- The Cutting Edge: A Clinicopathology Minireview of Immunoglobulin A Nephropathy
- Implications of Early Decline in eGFR Due to Intensive BP Control for Cardiovascular Outcomes in SPRINT
- Kappa-Restricted IgA Nephropathy Treated Successfully With Targeted-Release Budesonide
- New Agents in Treatment of Hyperkalemia: An Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease
- Blood Pressure and Living Kidney Donors: A Clinical Perspective
- Nephrotoxicity Induced by Intravitreal Vascular Endothelial Growth Factor Inhibitors: Emerging Evidence
Insurance
- Aetna
- Anthem Blue Cross
- Blue Shield of California
- Centivo
- Cigna
- First Health
- Health Net of California
- Interplan (part of HealthSmart)
- Medicare Advantage
- MultiPlan
- UFCM Health System
- Prime Health Services
- Private Healthcare Systems (PHCS)
- TRICARE
- UnitedHealthcare
The list of healthcare plans above may not be comprehensive and could change.
Please contact your benefits coordinator or health insurance company directly to verify coverage.
Visit our health insurance information page for more details.